Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments
After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug...
Nemera lay the first brick of a new manufacturing building
Yesterday, in the presence of numerous guests, the new project partners NEMERA and NOVO NORDISK laid the foundation stone for a new manufacturing Hall. The new building will be...
Nemera’s preservative-free multidose eye dropper Novelia approved for Santen’s Cosop, for Glaucoma treatments in 29 European countries
Santen announced that the preservative-free formulation Cosopt iMulti® will launch in 29 European countries in the coming months.
Nemera’s Innovation Center reaches 100 employees
Nemera’s celebrated an important milestone: its Innovation Center has just hired its 100th employee.
The e-Novelia ophthalmic add-on developed by Nemera wins the ‘Excellence in Pharma: Drug Delivery Devices’ Award at CPhI Worldwide 2018
A team of industry experts awarded Nemera’s electronic add-on for ophthalmic droppers with a prestigious CPhI Award for Best Drug Delivery Device in its category
Nemera receives drug manufacturing authorisation for its Neuenburg plant in Germany
Important achievement for Nemera, now able to handle, assemble, sterilize and store pharmaceutical drugs and medicinal products for autoinjectors.
Nemera has won the ‘Editor’s choice’ category at the annual INTERPHEX Awards, for its 2 steps-autoinjector Safelia
INTERPHEX and a team of industry experts select Nemera (booth 1636) as winner for this year’s exhibitor awards as Editor’s choice.
The Safelia autoinjector developed by Nemera wins the 'Exhibitor innovation' award at Pharmapack
A team of industry experts reward Nemera's autoinjector with a Pharmapack Award as best innovation product.